SUMMARY Glucagon-like peptide-1 (GLP-1) and its analogs act as appetite suppressants and have been proven to be clinically efficacious in reducing body weight in obese individuals. Central GLP-1 is expressed in a small population of brainstem cells located in the nucleus tractus solitarius (NTS), which project to a wide range of brain areas. However, it remains unclear how endogenous GLP-1 released in the brain contributes to appetite regulation. By using chemogenetic tools, we discovered that central GLP-1 acts on the midbrain ventral tegmental area (VTA) and suppresses high-fat food intake. We used integrated pathway tracing and synaptic physiology to further demonstrate that activation of GLP-1 receptors specifically reduces the excitatory synaptic strength of dopamine (DA) neurons within the VTA that project to the nucleus accumbens (NAc) medial shell. These data suggest that GLP-1 released from NTS neurons can reduce highly palatable food intake by suppressing mesolimbic DA signaling.
Gain-of-toxic-function mutations in Seipin (Asparagine 88 to Serine (N88S) and Serine 90 to Leucine (S90L) mutations, both of which disrupt the N-glycosylation) cause autosomal dominant motor neuron diseases. However, the mechanism of how these missense mutations lead to motor neuropathy is unclear. Here, we analyze the impact of disruption of N-glycosylation of Seipin on synaptic transmission by overexpressing mutant Seipin in cultured cortical neurons via lentiviral infection. Immunostaining shows that over-expressed Seipin is partly colocalized with synaptic vesicle marker synaptophysin. Electrophysiological recordings reveal that the Seipin mutation significantly decreases the frequency, but not the amplitudes of miniature excitatory post-synaptic currents and miniature inhibitory post-synaptic currents. The amplitude of both evoked excitatory post-synaptic currents and inhibitory post-synaptic current is also compromised by mutant Seipin over-expression. The readily releasable pool and vesicular release probability of synaptic vesicles are both altered in neurons over-expressing Seipin-N88S, whereas neither c-amino butyric acid (GABA) nor a-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) induced whole cell currents are affected. Moreover, electron microscopy analysis reveals decreased number of morphologically docked synaptic vesicles in Seipin-N88S-expressing neurons. These data demonstrate that Seipin-N88S mutation impairs synaptic neurotransmission, possibly by regulating the priming and docking of synaptic vesicles at the synapse. Keywords: AMPA receptor, EPSC, GABA, glutamate, IPSC, neurotransmission. J. Neurochem. (2014) 129, 328-338.Berardinelli-Seip Congenital Lipodystrophy Type 2 (BSCL2), a rare autosomal recessive disease, is characterized by a loss of adipose tissue and often accompanied by severe hypertriglyceridemia, insulin resistance, and moderate intellectual impairment (Agarwal et al. 2003;Fu et al. 2004;Magre et al. 2001). The BSCL2 gene encodes Seipin, which is important for lipid droplet morphology and adipocyte differentiation (Chen et al. 2012;Cui et al. 2011). Most mutations of Seipin associated with lipodystrophy contain non-sense, frame-shift, or aberrant splicing mutations that produce Received September 16, 2013; revised manuscript received November 18, 2013; accepted December 12, 2013. Address correspondence and reprint requests to Weiping Han, #02-02 Helios, 11 Biopolis Way, Singapore 138667. E-mail: weiping_han@ sbic.a-star.edu.sg or Zhiping Pang, 89 French Street, New Brunswick, NJ 08901, USA. E-mail: Zhiping.pang@rutgers.eduAbbreviations used: AMPA, a-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; dHMN-V, distal hereditary motor neuropathy type V; EPSC, miniature excitatory post-synaptic currents; mIPSC, miniature inhibitory post-synaptic currents; PBS, phosphate-buffered saline; PPR, paired-pulse ratio; RRP, readily releasable pool. 328
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.